Skip to content

The safety study of EMLA cream for non-coring needle insertion in patients with TIAP

The safety study of EMLA cream for non-coring needle insertion in patients with TIAP

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400093911
Enrollment
Unknown
Registered
2024-12-13
Start date
2023-12-06
Completion date
Unknown
Last updated
2024-12-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neoplasm

Interventions

Intervention group:the EMLA ceam was kept for one hour at the site of the cannulation, and was wiped off with sterile gauze before puncture
control group:the medical vaseline was kept for one hour at the site of the cannulation, and was wiped off with sterile gauze before puncture

Sponsors

Sun Yat-sen University Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1)TIAP was implanted in the chest wall, 2)the end of the infusion port catheter was well positioned from the lower 1/3 of the superior vena cava to the connection between the superior vena cava and the right atrium, 3) the expected follow-up treatment time exceeds 6 months; 4)more than 18 years old, 5)patients were aware of their condition, 6) informed consent to participate in this study.

Exclusion criteria

Exclusion criteria: 1) skin surface lesions at the site of TIAP, 2) EMLA cream or dressing allergy or drug allergen unknown, 3)local lymph node metastasis at the site of TIAP, 4).significant coagulation disorders, 5).pain or treatment with analgesic drugs now, 6)receiving drugs with local anesthetic components, 7)patients with psychiatric disorders who are unable to cooperate with the complete survey

Design outcomes

Primary

MeasureTime frame
complication;

Secondary

MeasureTime frame
Pain;Skin irritation response;Comfort;

Countries

China

Contacts

Public ContactSimei Shi

Sun Yat-sen University Cancer Center

shism@sysucc.org.cn+86 20 8734 2479

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026